SCHEMBL18909452

SCHEMBL18909452

CCC(=O)N1CCC(N2CCn3nccc3C2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 2/20 0.42
ACACA Q13085 2/20 0.42
KDM6B O15054 1/20 0.41
KDM5C P41229 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
KDM2A Q9Y2K7 1/20 0.41
KDM3A Q9Y4C1 1/20 0.41
KDM4E B2RXH2 2/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
EPHX2 P34913 5/20 0.39
ACHE P22303 3/20 0.39
JAK2 O60674 1/20 0.39
JAK1 P23458 1/20 0.39
DRD2 P14416 3/20 0.38
DRD4 P21917 3/20 0.38
DRD3 P35462 3/20 0.38
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24521443 0.87 JAK2 (0.39) KDM4ECYP2C9CYP2C19ACHEJAK2
SCHEMBL22030477 0.86 FAAH (0.43) KDM4ECYP2C9CYP2C19ACHEJAK2
SCHEMBL15998855 0.82 BLM (0.43) EPHX2DRD2DRD4DRD3
SCHEMBL18909108 0.77 ACACB (0.42) ACACBACACAKDM6BKDM5CKDM4C
SCHEMBL18909109 0.76 KDM6B (0.40) ACACBACACAKDM6BKDM5CKDM4C
SCHEMBL18909339 0.71 KDM4E (0.40) ACACBACACAKDM4ECYP2C9CYP2C19
SCHEMBL18909106 0.70 EPHX2 (0.43) ACACBACACAKDM4ECYP2C9CYP2C19
SCHEMBL18909099 0.70 HRH3 (0.47) KDM4ECYP2C9CYP2C19EPHX2ACHE
SCHEMBL18909112 0.70 ACHE (0.51) ACACBACACAKDM4ECYP2C9CYP2C19
SCHEMBL12313355 0.69 MEN1 (0.54) KDM4ECYP2C19EPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596072-B1 PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-06-22 EP disclosed
EP-3416967-B1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-02-09 EP disclosed
EP-3380474-B1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF HOFFMANN LA ROCHE (CH) 2019-08-21 EP disclosed
WO-2017140825-A1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-08-24 WO disclosed
WO-2017089390-A1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-06-01 WO disclosed